{"id":"etoposide-ifosfamide-methotrexate","safety":{"commonSideEffects":[{"rate":null,"effect":"Myelosuppression (neutropenia, thrombocytopenia, anemia)"},{"rate":null,"effect":"Nausea and vomiting"},{"rate":null,"effect":"Mucositis"},{"rate":null,"effect":"Alopecia"},{"rate":null,"effect":"Hemorrhagic cystitis (ifosfamide-related)"},{"rate":null,"effect":"Nephrotoxicity"},{"rate":null,"effect":"Neurotoxicity"}]},"_chembl":{"chemblId":"CHEMBL1200645","moleculeType":"Small molecule","molecularWeight":"668.54"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Etoposide is a topoisomerase II inhibitor that prevents DNA unwinding and repair. Ifosfamide is an alkylating agent that cross-links DNA strands. Methotrexate is an antimetabolite that inhibits dihydrofolate reductase, blocking nucleotide synthesis. Together, these agents target rapidly dividing cancer cells through complementary cytotoxic pathways.","oneSentence":"This is a combination chemotherapy regimen that kills cancer cells by damaging DNA and preventing cell division through multiple mechanisms.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:11:46.214Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Pediatric and adolescent cancers (lymphomas, sarcomas, and other solid tumors)"},{"name":"High-risk or relapsed/refractory malignancies"}]},"trialDetails":[{"nctId":"NCT04881838","phase":"PHASE3","title":"CCCG-ALCL-2020 for Chinese Children and Adolescents With Newly Diagnosed High-risk ALCL","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2021-03-01","conditions":"Pediatric Anaplastic Large Cell Lymphoma","enrollment":172},{"nctId":"NCT05681260","phase":"PHASE3","title":"Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)","status":"RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2023-02-06","conditions":"T-cell Lymphoblastic Lymphoma","enrollment":200},{"nctId":"NCT02845882","phase":"PHASE3","title":"LBL-2016 for Children or Adolescents in China","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Cancer Group, China","startDate":"2016-01","conditions":"Lymphoblastic Lymphoma","enrollment":150},{"nctId":"NCT03007147","phase":"PHASE3","title":"Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2017-08-08","conditions":"Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Mixed Phenotype Acute Leukemia","enrollment":475},{"nctId":"NCT07321912","phase":"PHASE2","title":"Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma","status":"NOT_YET_RECRUITING","sponsor":"Milton S. Hershey Medical Center","startDate":"2026-04-01","conditions":"Osteosarcoma, Ewing Sarcoma, Ewing Sarcoma Metastatic","enrollment":406},{"nctId":"NCT03643133","phase":"PHASE2","title":"Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2018-10-23","conditions":"Osteosarcoma","enrollment":60},{"nctId":"NCT06520163","phase":"PHASE3","title":"Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma","status":"RECRUITING","sponsor":"The Affiliated People's Hospital of Ningbo University","startDate":"2024-08-01","conditions":"Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization","enrollment":99},{"nctId":"NCT02112916","phase":"PHASE3","title":"Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-10-04","conditions":"Adult T Acute Lymphoblastic Leukemia, Ann Arbor Stage II Adult Lymphoblastic Lymphoma, Ann Arbor Stage II Childhood Lymphoblastic Lymphoma","enrollment":847},{"nctId":"NCT03719105","phase":"EARLY_PHASE1","title":"Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma","status":"RECRUITING","sponsor":"New York Medical College","startDate":"2019-03-01","conditions":"NK-Cell Lymphoma, NK-Cell Leukemia, Peripheral T Cell Lymphoma","enrollment":40},{"nctId":"NCT00878254","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"University of Miami","startDate":"2009-03-25","conditions":"Mantle-Cell Lymphoma","enrollment":25},{"nctId":"NCT02329080","phase":"PHASE2","title":"New Combination of Chemoimmunotherapy for Systemic B-cell Lymphoma With Central Nervous System Involvement","status":"COMPLETED","sponsor":"International Extranodal Lymphoma Study Group (IELSG)","startDate":"2014-12","conditions":"Diffuse Large B-cell Lymphoma","enrollment":79},{"nctId":"NCT00470223","phase":"PHASE3","title":"Combined Chemotherapy With or Without Zoledronic Acid for Patients With Osteosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"UNICANCER","startDate":"2007-03","conditions":"Sarcoma","enrollment":318},{"nctId":"NCT05827549","phase":"PHASE2","title":"Evaluation of Treatment Efficacy According to Risk Group in Relapsed Childhood Acute Lymphoblastic Leukemia","status":"RECRUITING","sponsor":"Ho Joon Im","startDate":"2024-04-04","conditions":"Acute Lymphoid Leukemia","enrollment":90},{"nctId":"NCT03643276","phase":"PHASE3","title":"Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017","status":"RECRUITING","sponsor":"Martin Schrappe","startDate":"2018-07-15","conditions":"Acute Lymphoblastic Leukemia, Pediatric","enrollment":5000},{"nctId":"NCT03206671","phase":"PHASE3","title":"Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and Adolescents","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospital Muenster","startDate":"2017-08-03","conditions":"Mature B-cell Non-Hodgkin Lymphoma","enrollment":650},{"nctId":"NCT01979536","phase":"PHASE2","title":"Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2013-11-13","conditions":"Anaplastic Large Cell Lymphoma, ALK-Positive, Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma, Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma","enrollment":137},{"nctId":"NCT00039130","phase":"PHASE2","title":"Rituximab, Chemotherapy, and Filgrastim in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"2002-05","conditions":"Leukemia, Lymphoma","enrollment":105},{"nctId":"NCT00667342","phase":"PHASE2","title":"A Study of Bevacizumab in Combination With Chemotherapy for Treatment of Osteosarcoma","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"2008-06-03","conditions":"Osteosarcoma, Malignant Fibrous Histiocytoma (MFH) of Bone","enrollment":43},{"nctId":"NCT00134030","phase":"PHASE3","title":"Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2005-11-14","conditions":"Localized Osteosarcoma, Metastatic Osteosarcoma","enrollment":1334},{"nctId":"NCT00199056","phase":"PHASE4","title":"German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)","status":"COMPLETED","sponsor":"Goethe University","startDate":"1999-10","conditions":"Adult Acute Lymphocytic Leukemia","enrollment":225},{"nctId":"NCT05518383","phase":"PHASE4","title":"B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021","status":"RECRUITING","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2022-05-25","conditions":"Non-hodgkin Lymphoma,B Cell, Burkitt Lymphoma, Primary Mediastinal Lymphoma","enrollment":300},{"nctId":"NCT00199082","phase":"PHASE4","title":"Newly Diagnosed Mature B-ALL, Burkitt's Lymphoma and Other High-grade Lymphoma in Adults","status":"COMPLETED","sponsor":"Nicola Goekbuget","startDate":"2002-07","conditions":"Burkitt's Lymphoma, Burkitt's Leukemia, Mediastinal Neoplasms","enrollment":650},{"nctId":"NCT00006455","phase":"PHASE3","title":"Combination Chemotherapy in Treating Children With Anaplastic Large Cell Lymphoma (ALCL 99)","status":"COMPLETED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"1999-11-26","conditions":"Lymphoma","enrollment":885},{"nctId":"NCT01117441","phase":"PHASE3","title":"International Collaborative Treatment Protocol For Children And Adolescents With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2010-06","conditions":"Leukemia","enrollment":6136},{"nctId":"NCT01481272","phase":"PHASE2","title":"Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients","status":"COMPLETED","sponsor":"Polish Lymphoma Research Group","startDate":"2011-11","conditions":"Diffuse Large B Cell Lymphoma","enrollment":77},{"nctId":"NCT05049473","phase":"PHASE2","title":"Treatment of Mature B-ALL and Burkitt Lymphoma (BL) in Adult Patients. BURKIMAB-14.","status":"UNKNOWN","sponsor":"PETHEMA Foundation","startDate":"2014-01","conditions":"Mature B-Cell Leukemia Burkitt Type, Burkitt Lymphoma (BL), Unclassifiable Lymphoma Between DCBL and BL","enrollment":100},{"nctId":"NCT02788201","phase":"PHASE2","title":"Genomic Based Assignment of Therapy in Advanced Urothelial Carcinoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2017-03-27","conditions":"Urothelial Carcinoma, Bladder Cancer, Urinary Bladder Neoplasms","enrollment":8},{"nctId":"NCT00720109","phase":"PHASE2, PHASE3","title":"Dasatinib and Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-07-14","conditions":"Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1","enrollment":63},{"nctId":"NCT00392990","phase":"PHASE2","title":"Doxorubicin Hydrochloride Liposome and Rituximab With Combination Chemotherapy in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Burkitt-Like Lymphoma","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2007-02-06","conditions":"Lymphoma","enrollment":25},{"nctId":"NCT00002835","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1995-10-30","conditions":"Lymphoma","enrollment":116},{"nctId":"NCT00002865","phase":"PHASE2","title":"High-Intensity, Brief-Duration Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"1995-04","conditions":"Leukemia","enrollment":25},{"nctId":"NCT00392834","phase":"PHASE2","title":"Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma","status":"COMPLETED","sponsor":"AIDS Malignancy Consortium","startDate":"2006-09","conditions":"Lymphoma","enrollment":34},{"nctId":"NCT03479918","phase":"PHASE3","title":"R-BL-M-04 Versus R-(DA)-EPOCH and Autologous Stem Cells Transplantation in Patients With High-Grade B-cell Lymphoma Double-hit (HGBL DH) and High-Grade B-cell Lymphoma Not Otherwise Specified (HGBL NOS)","status":"UNKNOWN","sponsor":"Elena N.Parovichnikova","startDate":"2018-03-15","conditions":"Lymphoma, High-Grade","enrollment":80},{"nctId":"NCT00354107","phase":"PHASE1, PHASE2","title":"Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2007-01","conditions":"Anaplastic Large Cell Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma","enrollment":5},{"nctId":"NCT03383406","phase":"PHASE2","title":"A Phase II Trial of Ifosfamide, Etoposide, Cytarabine, and Methotrexate (IVAM) Chemotherapy for Refractory or Relapsed Diffuse Large B Cell Lymphoma","status":"UNKNOWN","sponsor":"Asan Medical Center","startDate":"2016-12-01","conditions":"Diffuse Large B Cell Lymphoma","enrollment":30},{"nctId":"NCT01746992","phase":"PHASE4","title":"CTOP/ITE/MTX Compared With CHOP as the First-line Therapy for Newly Diagnosed Young Patients With T Cell Lymphoma","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2012-09","conditions":"ALK-negative Anaplastic Large Cell Lymphoma, Peripherial T Cell Lymphoma,Not Otherwise Specified, Angioimmunoblastic T Cell Lymphoma","enrollment":200},{"nctId":"NCT00554164","phase":"PHASE3","title":"Positron Emission Tomography Guided Therapy of Aggressive Non-Hodgkin's Lymphomas","status":"COMPLETED","sponsor":"University Hospital, Essen","startDate":"2007-11","conditions":"Lymphoma, High-grade","enrollment":1073},{"nctId":"NCT02842931","phase":"PHASE3","title":"R-Dose-adjusted (DA) - EPOCH-21 Versus R-modified Non-Hodgkin Lymphoma (NHL)-Berlin-Frankfurt-Munster (BFM)-90 Program (mNHL-BFM-90) and Autologous Stem Cells Transplantation (Auto-SCT) in DLBCL With Poor Prognosis","status":"UNKNOWN","sponsor":"National Research Center for Hematology, Russia","startDate":"2015-02","conditions":"Diffuse Large B-Cell Lymphoma","enrollment":300},{"nctId":"NCT00002494","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Alliance for Clinical Trials in Oncology","startDate":"1992-05","conditions":"Leukemia, Lymphoma","enrollment":134},{"nctId":"NCT01788137","phase":"PHASE3","title":"A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2008-01","conditions":"T-cell Lymphoma Adults, Previously Untreated, High Risk","enrollment":380},{"nctId":"NCT00450801","phase":"PHASE2","title":"R-MACLO-IVAM and Thalidomide in Untreated Mantle Cell Lymphoma","status":"COMPLETED","sponsor":"University of Miami","startDate":"2004-04","conditions":"Lymphoma","enrollment":22},{"nctId":"NCT00317408","phase":"NA","title":"Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma","status":"UNKNOWN","sponsor":"European Inter-group Cooperation on Childhood and Adolescent Non Hodgkin Lymphoma","startDate":"2004-04","conditions":"Lymphoma","enrollment":96},{"nctId":"NCT02531841","phase":"PHASE3","title":"High-dose Chemotherapy and ASCT or Consolidating Conventional Chemotherapy in Primary CNS Lymphoma","status":"UNKNOWN","sponsor":"University Hospital Freiburg","startDate":"2014-07","conditions":"Diffuse Large B-cell-lymphoma","enrollment":250},{"nctId":"NCT01501149","phase":"PHASE4","title":"Treatment of Natural Killer/T Cell Lymphoma-Ⅲ/Ⅳ","status":"UNKNOWN","sponsor":"Mingzhi Zhang","startDate":"2011-01","conditions":"Nasal and Nasal-type NK/T-cell Lymphoma","enrollment":80},{"nctId":"NCT01238159","phase":"PHASE2","title":"Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2010-08","conditions":"Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type","enrollment":30},{"nctId":"NCT00613457","phase":"PHASE3","title":"Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Associazione Italiana Ematologia Oncologia Pediatrica","startDate":"2000-09","conditions":"Leukemia","enrollment":2039},{"nctId":"NCT01290120","phase":"PHASE2","title":"Chemotherapy Plus Rituximab Combination for Adult Lymphoblastic Leukemia (B-ALL) and Burkitt's Non-Hodgkin Lymphoma","status":"COMPLETED","sponsor":"Northern Italy Leukemia Group","startDate":"2002-11","conditions":"Burkitt Lymphoma, B-ALL","enrollment":182},{"nctId":"NCT00003937","phase":"PHASE3","title":"Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1999-09","conditions":"Cardiac Toxicity, Sarcoma","enrollment":253},{"nctId":"NCT00742924","phase":"PHASE1","title":"Zoledronic Acid and Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Osteosarcoma","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2008-08","conditions":"Sarcoma","enrollment":24},{"nctId":"NCT00022737","phase":"PHASE3","title":"Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Children With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2002-10","conditions":"Childhood Acute Lymphoblastic Leukemia in Remission, Recurrent Childhood Acute Lymphoblastic Leukemia","enrollment":220},{"nctId":"NCT00012311","phase":"PHASE2","title":"Chemotherapy Plus Peripheral Stem Cell Transplantation Compared With Chemotherapy Alone in Treating Women With Stage IV Breast Cancer","status":"UNKNOWN","sponsor":"Herbert Irving Comprehensive Cancer Center","startDate":"2000-01","conditions":"Breast Cancer","enrollment":""},{"nctId":"NCT00278278","phase":"PHASE3","title":"Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas","status":"UNKNOWN","sponsor":"German Society for Pediatric Oncology and Hematology GPOH gGmbH","startDate":"2003-09","conditions":"Brain and Central Nervous System Tumors","enrollment":150},{"nctId":"NCT00040690","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia","status":"COMPLETED","sponsor":"Medical Research Council","startDate":"2008-11","conditions":"Leukemia, Lymphoma","enrollment":120},{"nctId":"NCT01258634","phase":"PHASE1","title":"A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2010-07","conditions":"Osteosarcoma, Lung Metastases","enrollment":2},{"nctId":"NCT00058461","phase":"PHASE2","title":"Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2003-11","conditions":"B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Burkitt Lymphoma, Childhood Diffuse Large Cell Lymphoma","enrollment":82},{"nctId":"NCT00002531","phase":"PHASE2","title":"Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia","status":"UNKNOWN","sponsor":"Johann Wolfgang Goethe University Hospital","startDate":"1993-01","conditions":"Leukemia","enrollment":""},{"nctId":"NCT00669812","phase":"PHASE2","title":"High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma","status":"UNKNOWN","sponsor":"Cancer Research UK","startDate":"2008-02","conditions":"Lymphoma, Small Intestine Cancer","enrollment":60},{"nctId":"NCT00974792","phase":"PHASE2","title":"Combination Chemotherapy and Rituximab in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma","status":"UNKNOWN","sponsor":"Cancer Research UK","startDate":"2006-01","conditions":"Lymphoma","enrollment":150},{"nctId":"NCT00002816","phase":"PHASE3","title":"Combination Chemotherapy in Treating Children With Relapsed Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"1996-12","conditions":"Leukemia","enrollment":120},{"nctId":"NCT00005977","phase":"PHASE3","title":"Combination Chemotherapy in Treating Patients With Non-Hodgkin's Lymphoma or Acute Lymphocytic Leukemia","status":"COMPLETED","sponsor":"Children's Oncology Group","startDate":"2000-09","conditions":"Leukemia, Lymphoma","enrollment":83},{"nctId":"NCT00012051","phase":"PHASE3","title":"Chemotherapy and Peripheral Stem Cell Transplant With or Without Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"Commissie Voor Klinisch Toegepast Onderzoek","startDate":"2000-09","conditions":"Lymphoma","enrollment":340},{"nctId":"NCT00002532","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Lymphocytic Leukemia","status":"UNKNOWN","sponsor":"Hannover Medical School","startDate":"1993-01","conditions":"Leukemia","enrollment":""},{"nctId":"NCT00430118","phase":"PHASE3","title":"Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia","status":"COMPLETED","sponsor":"University Hospital Schleswig-Holstein","startDate":"2000-07","conditions":"Leukemia","enrollment":4559},{"nctId":"NCT00126191","phase":"PHASE2","title":"Intensive Chemotherapy and Rituximab in the Treatment of Burkitt Lymphoma","status":"TERMINATED","sponsor":"Dana-Farber Cancer Institute","startDate":"2005-07","conditions":"Burkitt Lymphoma, Non-Hodgkins Lymphoma, Atypical Burkitt Lymphoma","enrollment":10},{"nctId":"NCT00023998","phase":"PHASE2","title":"Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2001-07","conditions":"Metastatic Osteosarcoma","enrollment":80},{"nctId":"NCT00002524","phase":"PHASE2","title":"Combination Chemotherapy in Treating Patients With AIDS-Related Lymphoma","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"1993-06","conditions":"Lymphoma","enrollment":46},{"nctId":"NCT01083342","phase":"PHASE2","title":"High-Dose (HD) Methotrexate (MTX) Induction Chemotherapy Followed by Alternative HD MTX-based and HD Cytarabine-based Combination Consolidation Chemotherapy for Newly Diagnosed Primary CNS Lymphoma; CISL 10-01 Study","status":"COMPLETED","sponsor":"Samsung Medical Center","startDate":"2010-01","conditions":"CNS Lymphoma","enrollment":36},{"nctId":"NCT00018954","phase":"PHASE2","title":"Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"1992-10","conditions":"Leukemia, Lymphoma","enrollment":""},{"nctId":"NCT01148173","phase":"PHASE2","title":"High-dose Chemotherapy and Stem Cell Transplantation for Central Nervous System (CNS) Relapse of Aggressive Lymphomas","status":"UNKNOWN","sponsor":"Charite University, Berlin, Germany","startDate":"2007-10","conditions":"Lymphoma, Non-Hodgkin","enrollment":30},{"nctId":"NCT00689845","phase":"NA","title":"Combination Chemotherapy and Rituximab in Treating Patients With Primary Mediastinal Diffuse Large B-Cell Lymphoma","status":"UNKNOWN","sponsor":"University Hospital Southampton NHS Foundation Trust","startDate":"2007-06","conditions":"Lymphoma","enrollment":120},{"nctId":"NCT00764907","phase":"PHASE3","title":"Risk-Adjusted Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia","status":"UNKNOWN","sponsor":"University Hospital, Motol","startDate":"2002-11","conditions":"Leukemia","enrollment":4000},{"nctId":"NCT00696735","phase":"PHASE3","title":"High-Dose Therapy Treatment in Patients With Follicular Lymphoma","status":"COMPLETED","sponsor":"French Innovative Leukemia Organisation","startDate":"1994-06","conditions":"Follicular Lymphoma","enrollment":172},{"nctId":"NCT00187070","phase":"NA","title":"Large Cell Lymphoma Pilot Study III","status":"COMPLETED","sponsor":"St. Jude Children's Research Hospital","startDate":"1997-12","conditions":"Lymphoma, Large Cell, Lymphoma, Non-Hodgkin","enrollment":8},{"nctId":"NCT00517894","phase":"","title":"Dose-Dense Therapy in Aggressive Lymphoma","status":"NO_LONGER_AVAILABLE","sponsor":"Arbeitsgemeinschaft medikamentoese Tumortherapie","startDate":"","conditions":"Lymphoma","enrollment":""},{"nctId":"NCT00180908","phase":"PHASE3","title":"Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma Children","status":"COMPLETED","sponsor":"Gustave Roussy, Cancer Campus, Grand Paris","startDate":"1994-06","conditions":"Osteosarcoma, Localised High Grade Osteosarcoma of the Limbs","enrollment":226}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Etoposide, Ifosfamide, Methotrexate","genericName":"Etoposide, Ifosfamide, Methotrexate","companyName":"Gustave Roussy, Cancer Campus, Grand Paris","companyId":"gustave-roussy-cancer-campus-grand-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a combination chemotherapy regimen that kills cancer cells by damaging DNA and preventing cell division through multiple mechanisms. Used for Pediatric and adolescent cancers (lymphomas, sarcomas, and other solid tumors), High-risk or relapsed/refractory malignancies.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}